-
Chembio Diagnostics Stock Is Trading Higher On FDA Emergency Use Nod For Its Partner's LumiraDX COVID-19 Antibody Test
Tuesday, August 3, 2021 - 3:41pm | 262The FDA has granted emergency use authorization to Chembio Diagnostics Inc's (NASDAQ: CEMI) partner LumiraDx's COVID-19 antibody test. LumiraDx and Chembio had announced a partnership on March 12, 2020 to develop point of care COVID-19 antibody test. The nod comes for...
-
Jobless Claims Unexpectedly Jump 32,000 to 360,000
Thursday, May 16, 2013 - 9:27am | 377In the week ending May 11, the advance figure for seasonally adjusted initial claims was 360,000, an increase of 32,000 from the previous week's revised figure of 328,000. The previous week was revised upward from 323,000 new claims. This compares to the year-ago figure of 373,000. This was the...
-
Jobless Claims Drop 4,000 to 5 1/2 Year Low
Thursday, May 9, 2013 - 9:56am | 373The U.S. Department of Labor reported Thursday morning that, in the week ending May 4, the advance figure for seasonally adjusted initial claims was 323,000, a decrease of 4,000 from the previous week's revised figure of 327,000. This is the lowest level of new claims since January 2008. The...